Recently, new immune-based treatments have shown impressive results when multiple myeloma returns, changing how doctors treat ...
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
While the fabled fountain of youth may not actually exist, a new type of therapy now does.
Under healthy conditions, the intestinal epithelium fully renews itself every three to five days. Aging and exposure to ...
A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...
Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...
Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on treatments tailored to each patient, this innovation uses specially engineered ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Imviva Biotech's CTD402 to accelerate the ...
UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results